Stay updated with breaking news from Commodore Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nkarta, Inc. (NASDAQ:NKTX – Get Free Report)’s share price rose 4.1% during mid-day trading on Wednesday after Canaccord Genuity Group raised their price target on the stock from $15.00 to $16.00. Canaccord Genuity Group currently has a buy rating on the stock. Nkarta traded as high as $10.53 and last traded at $10.27. Approximately 318,359 […]
Avalo acquires Phase 2-ready anti-IL-1β mAb, AVTX-009, through acquisition of AlmataBio, Inc.Topline results from planned Phase 2 trial in hidradenitis suppurativa expected in 2026Executed private placement financing of up to
Nkarta (NASDAQ:NKTX – Free Report) had its target price decreased by Mizuho from $31.00 to $25.00 in a report published on Friday morning, Benzinga reports. Mizuho currently has a buy rating on the stock. NKTX has been the subject of a number of other reports. HC Wainwright decreased their price target on Nkarta from $22.00 […]
Needham & Company LLC reaffirmed their buy rating on shares of Viridian Therapeutics (NASDAQ:VRDN – Free Report) in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has a $30.00 target price on the stock. Other equities analysts have also issued research reports about the stock. Oppenheimer increased their target price […]
HC Wainwright reiterated their buy rating on shares of Dyne Therapeutics (NASDAQ:DYN – Free Report) in a research report report published on Wednesday morning, Benzinga reports. They currently have a $36.00 target price on the stock. HC Wainwright also issued estimates for Dyne Therapeutics’ Q1 2024 earnings at ($0.83) EPS, Q2 2024 earnings at ($0.83) […]